On our latest Diabetech Live, I took a deep dive into the future of tubeless pumps and seven-day infusion sets, and shared the latest updates on the Twiist pump—along with real user feedback from its early launch. We also explored what’s next for Medtronic and Abbott in the CGM space. The discussion blended hands-on insights, audience questions, and honest conversations about what’s working, what still needs improvement, and what has me most excited about where diabetes technology is heading.

These live Q&As are something we’ll be doing every month exclusively for Diabetech All Access members—and all will be viewable on here the following week. Thank you to everyone who tuned in live and made this first show so special—you make everything we do possible

Join Diabetech All Access to view the full video below.